Ayurvedic drug helps in chronic kidney disease treatment

Update: 2017-03-08 18:10 GMT
As the world celebrates World Kidney Day on Thursday, there is good news for patients suffering from critical kidney disorders as an ayurvedic medicines have proved beneficial in treatment of the life taking disease.

According to a latest research, ayurvedic drug prepared of punarnava plant (Boerhavia diffusa) and other established kidney protective herbs in ayurvedic formulations have shown promising results in preventing and reducing the increased levels of kidney function parameters – serum creatinine.

The Global Burden of Disease (GBD) study 2015 ranked chronic kidney disease 17th among the causes of deaths globally. In India, GBD 2015 ranked chronic kidney disease as the eighth leading cause of death. Deaths due to renal failure in the country have rose to 36,000 in 2015 from 86,000 in 2003.

According to research paper published in The Indo American Journal of Pharmaceutical Research, the Neeri KFT, which is a blend of punarnava plant, leaves of lotus, patharchur and other key herbs, has proved to be a life saving drug for all those kidney patients who are under the regular dialysis. The drug has also helped in maintaining histological parameter of kidneys apart from reducing increased levels of uric acid and electrolytes. Commenting the development, a senior Ayush Ministry official said, "Such reports would help in building confidence among masses as ayurvedic medicines are still not the first choice among people. In terms of efficacy, the ayurvedic drugs are as effective as any modern medicine."

Hailing the efficacy of the drug, Professor KN Dwivedi of Banaras Hindu University's Department of Dravyaguna said, "Seeing the surge in kidney disease patients there is a need of a protective agent and Neeri KFT looks promising to fulfil all the needs of a kidney patient."

The drug has been introduced in the market by Aimil Pharmaceuticals, the manufacture of Council for Scientific and Industrial Research's (CSIR) maiden ayurvedic anti-diabetic drug BGR-34.

Similar News